Effect of multiplicity of infection on Newcastle disease virus-HeLa cell interaction.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMC 2137359)

Published in J Exp Med on February 01, 1961

Authors

E F WHEELOCK, I TAMM

Articles cited by this

Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med (1954) 68.67

VIRUS-CELL INTERACTION WITH A TUMOR-PRODUCING VIRUS. Proc Natl Acad Sci U S A (1960) 5.46

The specific amino acid requirements of a human carcinoma cell (Stain HeLa) in tissue culture. J Exp Med (1955) 5.03

Hemadsorption (adsorption-hemagglutination) test for viral agents in tissue culture with special reference to influenza. Proc Soc Exp Biol Med (1958) 3.51

A kinetic study of infection of chick embryo cells in vitro by Rous sarcoma virus. Virology (1959) 3.07

A study of the herpes simplex virus-rabbit kidney cell system by the plaque technique. Virology (1957) 2.61

Studies on deoxyribonucleic acid metabolism in human cancer cell cultures (HeLa). I. The temporal relationships of deoxyribonucleic acid synthesis to mitosis and turnover time. Lab Invest (1959) 2.16

A non-transmissible cytopathogenic effect of influenza virus in tissue culture accompanied by formation of non-infectious hemagglutinins. J Exp Med (1955) 1.95

Immunohistochemical studies on the interaction between Ehrlich ascites tumor cells and Newcastle disease virus. J Exp Med (1957) 1.85

Site of intracellular antigen production by myxoviruses. Proc Soc Exp Biol Med (1960) 1.66

Enumeration of cell-infecting particles of Newcastle disease virus by the fluorescent antibody technique. J Exp Med (1961) 1.64

A procedure which eliminates nonspecific inhibitor from human serum but does not affect specific antibodies against influenza viruses. J Immunol (1952) 1.63

Noninfectious forms of Newcastle disease and influenza viruses; studies on noninfectious virus occurring within cells that are producing fully infectious virus. Virology (1955) 1.51

Mitosis and division in HeLa cells infected with influenza or Newcastle disease virus. Virology (1959) 1.36

Infection and growth of Newcastle disease virus (NDV) in cultures of chick embryo lung epithelium. Virology (1957) 1.33

Host-cell interaction of animal viruses. I. Titration of cell-killing by viruses. Virology (1958) 1.33

The effect of herpes virus on HeLa cells dividing parasynchronously. Virology (1959) 1.17

Infection of the upper respiratory tract of the chick with a mild (vaccine) strain of Newcastle disease virus. II. Studies on the pathogenesis of the infection. Bull Johns Hopkins Hosp (1958) 1.06

Cytopathogenic effect of Newcastle virus in monkey kidney cultures and interference with poliomyelitis viruses. Proc Soc Exp Biol Med (1955) 0.94

Monolayer tissue cultures. III. Propagation of poliomyelitis viruses in cultures of trypsin-dispersed monkey kidney cells. J Immunol (1954) 0.94

Relation between multiplicity of exposure, adsorption, and cytopathogenic effect of poliomyelitis virus in monkey kidney tissue cultures. Virology (1955) 0.86

Latent period in monkey kidney and HeLa cell monolayer cultures infected with poliomyelitis virus. Proc Soc Exp Biol Med (1955) 0.79

Shortened latency' as a result of multiple infection by vesicular stomatitis virus in chick cell culture. J Gen Microbiol (1958) 0.79

Articles by these authors

Poliovirus-induced RNA polymerase and the effects of virus-specific inhibitors on its production. Proc Natl Acad Sci U S A (1963) 5.89

STUDIES ON THE MECHANISM OF POLIOVIRUS-INDUCED CELL DAMAGE. I. THE RELATION BETWEEN POLIOVIRUS,-INDUCED METABOLIC AND MORPHOLOGICAL ALTERATIONS IN CULTURED CELLS. Virology (1965) 5.21

Characterization and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Biol Med (1950) 4.86

ELECTRON MICROSCOPIC STUDY OF THE FORMATION OF POLIOVIRUS. Virology (1965) 3.71

A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses. J Exp Med (1952) 3.67

Reovirus type 3: physical characteristics and interaction with L cells. Virology (1962) 3.65

Quantitative titration of vaccinia virus on the chorioallantoic membrane. J Immunol (1956) 3.60

Inhibition of influenza virus multiplication by N-glycosides of benzimidazoles-N. J Exp Med (1954) 2.84

ENZYMIC SYNTHESIS OF RNA WITH REOVIRUS RNA AS TEMPLATE. I. CHARACTERISTICS OF THE REACTION CATALYZED BY THE RNA POLYMERASE FROM ESCHERICHIA COLI. J Mol Biol (1964) 2.47

Two kinds of particles with contrasting properties in influenza A virus strains from the 1957 pandemic. Virology (1959) 2.46

Spectrum and characteristics of the virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole. J Exp Med (1961) 2.20

Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. II. Measurement of inhibitory activity by hemagglutination titrations. J Exp Med (1953) 2.00

Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. III. Relationship between inhibitory activity and chemical structure. J Exp Med (1953) 1.79

Differences in the selective virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole and guanidine HCl. Virology (1962) 1.66

A new technique for dropping the chorioallantoic membrane in embryonated chicken eggs. J Lab Clin Med (1955) 1.65

Inhibition of influenza virus multiplication by 2,5-dimethylbenzimidazole. Yale J Biol Med (1952) 1.64

Enumeration of cell-infecting particles of Newcastle disease virus by the fluorescent antibody technique. J Exp Med (1961) 1.64

Fractional dilution procedure for precise titration of hemagglutinating viruses and hemagglutination-inhibiting antibodies. J Immunol (1953) 1.64

SPECIFIC INHIBITION OF REPLICATION OF ANIMAL VIRUSES. Science (1963) 1.62

Ultracentrifugation studies of a urinary mucoprotein which reacts with various viruses. J Biol Chem (1955) 1.60

Studies of two kinds of virus particles which comprise influenza A2 virus strains. II. Reactivity with virus inhibitors in normal sera. J Exp Med (1960) 1.56

Immunological characteristics of N.Y. strains of influenza A virus from the 1957 pandemic. Proc Soc Exp Biol Med (1958) 1.55

CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS. N Engl J Med (1965) 1.54

Inhibition of influenza and mumps virus multiplication by 4,5,6- (or 5,6,7-) trichloro-1-beta-D-ribofuranosyl-benzimidazole. Science (1954) 1.53

Biochemical basis for alterations in structure and function of HeLa cells infected with Newcastle disease virus. J Exp Med (1961) 1.52

Selective chemical inhibition of influenza B virus multiplication. J Bacteriol (1956) 1.51

Direct visualization of a mucoprotein component of urine. J Biol Chem (1955) 1.50

OBSERVATIONS ON THE REPEATED ADMINISTRATION OF VIRUSES TO A PATIENT WITH ACUTE LEUKEMIA. A PRELIMINARY REPORT. N Engl J Med (1964) 1.50

Reactive sites of reovirus type 3 and their interaction with receptor substances. Virology (1962) 1.47

STUDIES ON THE MECHANISM OF POLIOVIRUS-INDUCED CELL DAMAGE. II. THE RELATION BETWEEN POLIOVIRUS GROWTH AND VIRUS-INDUCED MORPHOLOGICAL CHANGES IN CELLS. Virology (1965) 1.47

ANIMAL AND PLANT VIRUSES WITH DOUBLE-HELICAL RNA. Proc Natl Acad Sci U S A (1963) 1.45

Influenza virus multiplication in the chorioallantoic membrane in vitro: kinetic aspects of inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. J Exp Med (1954) 1.45

The role of protein synthesis in the eclipse period of newcastle disease virus multiplication in HeLa cells as studied with puromycin. Proc Natl Acad Sci U S A (1962) 1.43

On the role of ribonucleic acid in animal virus synthesis. I. Studies with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. J Exp Med (1960) 1.42

Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. I. Kinetic aspects of inhibition by 2,5-dimethylbenzimidazole as measured by infectivity titrations. J Exp Med (1953) 1.41

Agglutination of bovine erythrocytes: a general characteristic of reovirus type 3. Proc Soc Exp Biol Med (1962) 1.41

INTERFERON IN HUMAN SERUM DURING CLINICAL VIRAL INFECTIONS. Lancet (1964) 1.40

MACROMOLECULAR SYNTHESIS IN REOVIRUS-INFECTED L CELLS. Biochim Biophys Acta (1963) 1.40

High inhibitory activity of certain halogenated ribofuranosylbenzimidazoles on influenza B virus multiplication. J Bacteriol (1956) 1.37

Influenza virus-erythrocyte interaction. I. Reversible reaction between Lee virus and cat erythrocytes. J Immunol (1954) 1.36

Mitosis and division in HeLa cells infected with influenza or Newcastle disease virus. Virology (1959) 1.36

Studies of two kinds of virus particles which comprise influenza A2 virus strains. III. Morphological characteristics: independence to morphological and functional traits. J Exp Med (1960) 1.35

An electrophoretic examination of a urinary mucoprotein which reacts with various viruses. J Exp Med (1952) 1.35

Enhancement of influenza virus multiplication by 5-methyl-2-D-ribobenzimidazole. Virology (1956) 1.32

Multiplication of vaccinia virus in the chorioallantoic membrane in vitro. Virology (1957) 1.28

On the role of ribonucleic acid in animal virus synthesis. II. Studies with ribonuclease. J Exp Med (1960) 1.27

2,(alpha-hydroxybenzyl)-benzimidazole (HBB) as an aid in virus classification. Virology (1961) 1.22

A new count of allontoic cells of the 10-day chick embryo. Proc Soc Exp Biol Med (1954) 1.16

Measurement of herpes simplex virus by the plaque technique in human amnion cells. J Immunol (1959) 1.12

Comparison of influenza B virus strains from the 1950 epidemic with strains from earlier epidemics. Proc Soc Exp Biol Med (1950) 1.11

COMPLETE AND CORELESS HEMAGGLUTINATING PARTICLES PRODUCED IN ECHO 12 VIRUS-INFECTED CELLS. Virology (1964) 1.11

Equivalence between vaccinia particles counted by electron microscopy and infectious units of the virus. Proc Soc Exp Biol Med (1957) 1.08

COXSACKIE A9 VIRUS: MUTATION FROM DRUG DEPENDENCE TO DRUG INDEPENDENCE. Science (1965) 1.06

Glycosides of chlorobenzimidazoles as inhibitors of poliovirus multiplication. Virology (1957) 1.04

Relationship between structure of benzimidazole derivatives and inhibitory activity on vaccinia virus multiplication. Virology (1957) 1.04

Relationship between structure of benzimidazole derivatives and selective virus inhibitory activity. Inhibition of poliovirus multiplication and cytopathic effects by 2-(alpha-hydroxybenzyl)-benzimidazole, and its 5-chloroderivative. J Exp Med (1961) 1.03

Prevention of virus interference by 2,5-dimethylbenzimidazole. J Immunol (1955) 1.01

INTERFERON IN DERMAL CRUSTS OF HUMAN VACCINIA VIRUS VACCINATIONS POSSIBLE EXPLANATION OF RELATIVE BENIGNITY OF VARIOLATION SMALLPOX. Proc Soc Exp Biol Med (1964) 0.98

THE DRUG-REQUIRING PHASE IN THE GROWTH OF DRUG-DEPENDENT ENTEROVIRUSES. Proc Natl Acad Sci U S A (1963) 0.96

INTRACELLULAR SITE OF NEWCASTLE DISEASE VIRUS NUCLEIC ACID SYNTHESIS. Proc Soc Exp Biol Med (1963) 0.96

ALTERED LOCATION OF PROTEIN SYNTHESIS IN THE CELL AFTER POLIOVIRUS INFECTION. Biochim Biophys Acta (1963) 0.95

EVIDENCE FOR UNCOUPLED SYNTHESIS OF VIRAL RNA AND VIRAL CAPSIDS. Virology (1964) 0.95

Growth curves of influenza virus based on hemagglutination titers in individual embryonated eggs. Yale J Biol Med (1951) 0.94

RESCUE OF DRUG-REQUIRING AND DRUG-INHIBITED ENTEROVIRUSES. Proc Natl Acad Sci U S A (1964) 0.93

Chemotherapy of viral and rickettsial diseases. Annu Rev Microbiol (1957) 0.92

THE RELATION OF PROTEIN SYNTHESIS TO FORMATION OF POLIOVIRUS RNA POLYMERASE. Virology (1963) 0.91

Base composition of the RNA of a reovirus variant. Science (1963) 0.89

Antiviral chemotherapy. Yale J Biol Med (1956) 0.87

SYNERGISTIC EFFECT OF 2-(ALPHA-HYDROXYBENZYL)-BENZIMIDAZOLE AND GUANIDINE ON PICORNAVIRUS REPRODUCTION. Nature (1963) 0.84

SYNTHESIS AND VIRUS-INHIBITORY ACTIVITY OF D- AND L-ISOMERS OF 2-(ALPHA-HYDROXY-BENZYL)-BENZIMIDAZOLE. Nature (1964) 0.83

THE DEVELOPMENT OF ULTRAVIOLET-IRRADIATION RESISTANCE BY POLIOVIRUS INFECTIVE CENTERS AND ITS INHIBITION BY GUANIDINE. Virology (1965) 0.81

The effect of monochromatic ultraviolet radiation on the infectivity and hemagglutinating ability of the influenza virus type A strain PR-8. J Bacteriol (1950) 0.79

Certain benzimidazoles, benzenes, and ribofuranosylpurines as inhibitors of influenza B virus multiplication. J Bacteriol (1956) 0.77

BIOCHEMISTRY OF VIRUS REPRODUCTION. Am J Med (1965) 0.76

Metabolic antagonists and selective virus inhibition. Clin Pharmacol Ther (1961) 0.76

Variation demonstrable by methods other than serological. Bull N Y Acad Med (1952) 0.75

Influenza virus-erythrocyte interaction. II. Effect of egg passage on the reaction between a recently recovered influenza A virus and sheep erythrocytes. J Immunol (1954) 0.75

Separation of hemagglutination inhibitors for GDVII and influenza viruses in normal allantoic fluid and human urine. J Immunol (1954) 0.75

[Selective inhibition of propagation of enteroviruses by 2-(a-hydroxy-benzyl)-benzimidazole]. Z Hyg Infektionskr (1961) 0.75

Antigenic similarity between the first and later egg passage strains of freshly recovered influenza A viruses. Proc Soc Exp Biol Med (1952) 0.75

Principles of antiviral chemotherapy. Antibiot Chemother (Northfield) (1962) 0.75